NYSE:RCUS (Arcus Biosciences)

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
  • Arcus Biosciences (NYSE: RCUS) Latest News

    No posts found.